The Day the FDA Answered Its Own Question

And Why the Market Hasn’t Priced This

What the FDA Published Today

The FDA released coordinated documents today — a Wall Street Journal op-ed by Commissioner Makary and formal draft guidance — on Rare Disease Day, the day before the President's State of the Union address. The timing is not incidental: Rare Disease Day provides the human context, the State of the Union provides the political backdrop, the WSJ provides the audience and the formal guidance provides the regulatory teeth. Each element was chosen deliberately, and together they signal something beyond incremental policy evolution: an administration staking public, political capital on a specific direction for rare disease drug development at the highest possible moment of national attention.